---
title: Buy Sitagliptin 50mg/100mg Pills Online
description: Sitagliptin 50mg/100mg pills help manage type 2 diabetes by improving blood sugar control in adults. Order from our secure online pharmacy for verified quality and reliable delivery.
type: product
language: en 
url: https://liabilis.com/order-sitagliptin-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 44.99
price_max: 359.99
currency: USD
offers:
  - name: 50mg x 10 pills
    price: 44.99
  - name: 50mg x 20 pills
    price: 85.99
  - name: 50mg x 30 pills
    price: 125.99
  - name: 50mg x 40 pills
    price: 159.99
  - name: 50mg x 60 pills
    price: 221.99
  - name: 50mg x 90 pills
    price: 321.99
  - name: 100mg x 10 pills
    price: 49.99
  - name: 100mg x 20 pills
    price: 94.99
  - name: 100mg x 30 pills
    price: 134.99
  - name: 100mg x 40 pills
    price: 172.99
  - name: 100mg x 60 pills
    price: 248.99
  - name: 100mg x 90 pills
    price: 359.99
---

# Buy Sitagliptin 50mg/100mg Pills Online

Sitagliptin is a DPP-4 inhibitor used to treat type 2 diabetes in adults. It works by helping the body release more insulin and control blood sugar levels after meals. This medication is suitable for patients needing oral therapy alongside diet and exercise. Our online pharmacy provides Sitagliptin in 50mg and 100mg pills.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **50mg** | 10 pills | **$44.99** | $4.50 | In Stock |
| **50mg** | 20 pills | **$85.99** | $4.30 | In Stock |
| **50mg** | 30 pills | **$125.99** | $4.20 | In Stock |
| **50mg** | 40 pills | **$159.99** | $4.00 | In Stock |
| **50mg** | 60 pills | **$221.99** | $3.70 | In Stock |
| **50mg** | 90 pills | **$321.99** | $3.58 | In Stock |
| **100mg** | 10 pills | **$49.99** | $5.00 | In Stock |
| **100mg** | 20 pills | **$94.99** | $4.75 | In Stock |
| **100mg** | 30 pills | **$134.99** | $4.50 | In Stock |
| **100mg** | 40 pills | **$172.99** | $4.32 | In Stock |
| **100mg** | 60 pills | **$248.99** | $4.15 | In Stock |
| **100mg** | 90 pills | **$359.99** | $4.00 | In Stock |


[Buy Now](https://liabilis.com/order-sitagliptin-online-en.html)

## Introduction
Sitagliptin is an oral medication used to improve blood-sugar control in adults with type 2 diabetes mellitus. The active ingredient is **sitagliptin phosphate**, supplied as a tablet in strengths of 50 mg and 100 mg. It belongs to the therapeutic class of di-peptidyl-peptidase 4 (D-type II) inhibitors. In addition to its primary indication for type 2 diabetes, the drug is sometimes prescribed off-label for conditions such as pre-diabetes and for individuals who have difficulty achieving target glycaemia with other agents.

## Quick Reference Facts
**Active Ingredient** 
: Sitagliptin phosphate 

**Form** 
: pill 50 mg | 100 mg 

**Primary and Off-Label Uses** 
: • Treatment of type 2 diabetes mellitus 
: • Adjunct to diet and exercise when other oral agents are inadequate (off-label) 
: • Early intervention in pre-diabetes in selected patients (off-label) 

## What is Sitagliptin?
Sitagliptin is the **generic version of medications containing the active compound sitagliptin phosphate**. It is marketed globally as the primary D-type II inhibitor for type 2 diabetes and is the generic equivalent of the branded drug **Janu Januvia** as well as combination products such as **Janumet** (sitagliptin + metformin). The formulation is a film-coated tablet designed for oral administration once daily. The compound was first approved by the U.S. Food and Disease Administration in 2006 and is now listed in many national pharmaco-pevidence bases. As a generic, it offers the same bio-equivalence, safety profile, and therapeutic benefit as the brand-name products, while providing a more affordable option for patients.

## How Sitagliptin Works
Sitagliptin selectively inhibits the enzyme di-peptidyl-peptidase 4 (DPP-4) that normally degrades the incre-tins - primarily glucagon-like peptide-1 (GL-GLP-1) and glucose-dependent insulin-tropic polypeptide (GIP). By preventing this degradation, sit-t-ag-lipt-in prolongs the activity of these hormone-mediated pathways. The physiological consequences are:

* **Enhanced insulin release** from pancreatic β-cell - especially when blood glucose is elevated.
* **Reduced gluc-prop-tion** of glucagon from α-cell - leading to decreased hepatic glucose output.
* **Improved post-prandial glucose excursions** without causing hypogly-ca-emia when used as monotherapy.

Pharmacokinetically, the tablet is absorbed rapidly, reaching peak plasma concentrations in 2-4 hours. The mean half-life is about 12 hours, allowing once-daily dosing. About 79 % of the dose is excreted unchanged in the urine; therefore renal function influences dosing adjustments. The drug is not substantially metabolized by the cy-Cy P450 system, which limits many drug-drug interactions.

## Conditions Treated with Sitagliptin
- **Type 2 diabetes mellitus** - By increasing insulin secretion and decreasing glucagon, sitagliptin improves fasting and post-prandial glucose, helping patients achieve target Hb-A1c when diet, exercise, and first-line agents (e.g., met-metformin) are insufficient. 
- **Combination therapy for type 2 diabetes** - When added to other oral antidi-diabetic agents (e.g., metformin, thiazolid-one, or a basal insulin), sitagliptin provides additive gly-c-emia reductions without markedly increasing the risk of hypogly-caemia. 

*Off-label*: Some clinicians employ sitagliptin in early-stage pre-diabetes or in patients who experience intolerance to first-line agents, although these uses have not received formal regulatory approval.

## Is Sitagliptin the Right Medication for You?
**Suitable patients** are adults diagnosed with type 2 diabetes whose glycaemia is not adequately controlled by diet, exercise, and first-line oral therapy. It is particularly advantageous for individuals who:

* Prefer a medication with a low risk of hyp­-o-glycemia when used alone.
* Have a limited need for frequent dose adjustments (once daily).
* May benefit from a tablet that does not require titration in most cases.

**Contra-indications and caution** include:

* Documented hypersensitivity to sitagliptin phosphate or any excipient in the tablet.
* Moderate to severe renal impairment (eG < 30 mL/min/1.73 m²) - dose reduction is required; in end-stage renal disease the drug is generally avoided.
* History of pancreatitis - the potential for recurrence necessitates careful benefit-risk assessment.
* Pregnancy or breastfeeding - benefits must be weighed against potential risks; it is not first-line in these populations.

Physicians may avoid sitagliptin in patients who are on strong CYP 3A4-interacting agents that can increase plasma concentrations, although such interactions are limited.

## Buying Sitagliptin from [our online pharmacy](https://liabilis.com/order-sitagliptin-online-en.html)

### Why Choose Our Service?
Accessing sitagliptin can be challenging in regions where the brand is scarce or priced above the national average. Our service offers a reliable way to obtain the generic formulation, reducing financial barriers while preserving therapeutic integrity.

### Quality & Safety Assurance
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) and is inspected by third-party auditors before shipment.

### Pricing & Access
The generic version of sitagliptin is offered at a price close to the manufacturer’s bulk rate, translating into noticeable savings compared to brand-name counterparts. This makes long-term therapy more sustainable for patients with chronic disease.

### Discre-t Delivery
All orders are packaged in plain, tamper-evidence-locked parcels. Most customers receive their medication within seven days via express courier, while standard airmail arrives in approximately three weeks, ensuring both speed and discretion.

## Use: Dosing, Missed Dose, Overdose
**Standard dosing** 
- 50 mg once daily for most adults with preserved renal function. 
- 100 mg once daily may be prescribed when tighter glycaemia is required and renal function is adequate (eG ≥ 50 mL/min). 

**Missed dose** 
- If you miss a dose, take it as soon as you remember on the same day. 
- Do not take a double dose the next morning; continue with the regular schedule. 

**Suspected overdose** 
- In the unlikely event of an overdose, seek immediate medical attention or contact a poison-center. 
- Symptoms may include nausea, vomiting, or unusually low blood glucose if combined with other hypogly-ca-emic agents. 

**Practical precautions** 
- Take the tablet with or without food; consistency improves absorption. 
- Alcohol does not directly interact but excessive intake may affect blood-sugar control. 
- Avoid driving or operating machinery if you experience dizziness or hypogly-cemia. 

## Safety Information

### ⚡️ Who Should Not Take Sitagliptin
- Individuals with known hypersensitivity to sitagliptin phosphate or any excipient. 
- Patients with severe renal impairment (eG < 30 mL/min/1.73 m²) unless a substantially reduced dose is prescribed. 
- Patients with a recent history of acute pancreatitis without thorough risk-benefit assessment. 

### Common Side Effects
- **Upper-respiratory tract infection** (e.g., nasopharyngitis) - generally mild and transient. 
- **Headache** - often resolves within a few days of initiation. 
- **Gastro-intestinal disturbances** such as nausea, diarrhea, or abdominal discomfort - tend to diminish as the body adapts. 

### Serious Side Effects (Seek Immediate Medical Help)
- **Pancreatitis** - severe abdominal pain radiating to the back, nausea, vomiting. 
- **Hypersensitivity reactions** - facial swelling, rash, or bronchial narrowing. 
- **Severe hypogly-emia** - especially when combined with insulin or a sulfonylurea; treat with rapid-acting glucose. 

### Drug & Food Interactions
- **Strong CYP 3A4 inhibitors** (e.g., ketoconazole, itraconazole) may increase sitagliptin exposure; monitor for adverse effects. 
- **Ruthenium 5** - not a known interaction but avoid concurrent use of unapproved herbal supplements without physician review. 
- **Insulin or sulfonylurea** - may potent-iate hypogly-emia; dose adjustments may be required. 

## Off-Label and Investigational Uses of Sitagllink
- **Prediabetes** - Small-scale studies suggest modest improvements in fasting glucose, but the benefit-risk profile remains under review. 
- **Type 1 diabetes adjunct** - Limited evidence indicates possible reduction in post-prandial glucose when added to insulin, yet this is not an approved application. 
- **Poly-poly-pharmacy for elderly patients** - Investigational use in older adults with multiple comor-m-date conditions to reduce the need for insulin; requires close monitoring. 

All off-label applications should be undertaken only under the direct supervision of a qualified healthcare professional, as they have not received formal approval from regulatory agencies.

## Storage & Handling
- Store the tablets at room temperature, between 20 °C and 25 °C (68 °F - 77 °F). 
- Protect from excessive moisture and direct sunlight. 
- Keep out of reach of children and pets. 
- Discard any tablets that are noticeably damaged, discolored, or beyond the printed expiration date. 

## Frequently Asked Questions

**Practical Use & Lifestyle**

- **Can I travel with sitagliptin across international borders?** 
 Yes, but retain the original packaging and a copy of the prescription. Some countries may require a letter from your physician for import. 

- **Will alcohol affect how sitagliptin works?** 
 Alcohol does not directly interfere with the drug’s enzymatic target, but excessive intake can worsen blood-sugar control and increase the risk of hypogly-emia when combined with other hyp-o-glycemic agents. 

- **Is it safe to take the tablet before a night-shift?** 
 The medication maintains activity for 12 hours, so taking it at the same time each day-regardless of shift-preserves its efficacy. 

**Product & Formulation Details**

- **What does a sitagliptin tablet look like?** 
 The generic tablet is typically white to off-white, film-coated, and round. 50 mg tablets may be smaller than the 100 mg version, but appearance can vary by manufacturer. 

- **Can I split a 100 mg tablet to adjust the dose?** 
 The tablet is not scored, and splitting may lead to uneven dosing. Use a prescribed 50 mg tablet if a lower dose is needed. 

- **Are there any inactive ingredients I should be aware of?** 
 Common excipients include lactose, magnesium stearate, and cellulose. Patients with specific allergies should review the full ingredient list provided by the pharmacy. 

**Regulatory & Safety Nuances**

- **Will sitagliptin show up on a standard athletic drug test?** 
 No, sitagliptin is not classified as a performance-enhancing substance and does not appear on typical anti-doping panels. 

- **Is the generic version subject to the same FDA scrutiny as the brand?** 
 Yes. Generic products must demonstrate bio-equivalence to the brand-name reference within a tight therapeutic window, ensuring comparable safety and efficacy. 

- **How does renal impairment affect my use of sitaglipti­n?** 
 Reduced kidney function decreases clearance, leading to higher plasma levels. The recommended approach is a lower starting dose (e.g., 50 mg) and possible further reduction based on eG. 

**Scientific & Clinical Curiosity**

- **What was the key clinical trial that established its place in therapy?**** 
 The “SIT-2006” phase III trial compared sitagliptin with placebo added to met-metformin and demonstrated a mean Hb-A1c reduction of 0.7 % after 24 weeks, confirming its add-on benefit. 

- **How does sitagliptin differ from earlier DPP-4 inhibitors?** 
 Compared with first-generation agents, sitagliptin offers a longer half-life and a higher selectivity for D-type II, resulting in fewer off-target effects and a more favorable tolerability profile. 

## Glossary
**Dipeptidyl-peptidase 4 (D-type II) inhibitor** 
: A class of oral antidi-diabetic agents that prolong the activity of incretin hormones, thereby enhancing insulin release and lowering blood glucose. 

**Bio-equivalence** 
: Demonstrated when a generic product yields the same rate and extent of absorption as the reference brand, within a narrow range of 80-125 % of the original. 

**eG (estimated glomer-file)** 
: A calculated value of kidney filtration that helps adjust medication dosing for patients with impaired renal function. 

## Disclaimer
The information provided about **Sitagliptin** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-sitagliptin-online-en.html) offers access to **Sitagliptin** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.